ALS patients get expanded access to experimental gold nanocrystal therapy
NCT ID NCT05281484
First seen Apr 05, 2026 · Last updated May 24, 2026 · Updated 7 times
Summary
This program gave up to 300 people with amyotrophic lateral sclerosis (ALS) access to an experimental drug called CNM-Au8. The main goal was to provide treatment, not to test if it works. Researchers also tracked safety by monitoring side effects. The program is no longer available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Barrow Neurological Institute
Phoenix, Arizona, 85013, United States
-
DUKE University Medical Center (Enrollment is full, not recruiting)
Durham, North Carolina, 27705, United States
-
Henry Ford Health Systems (Enrollment is full, not recruiting)
Detroit, Michigan, 48322, United States
-
Hospital for Special Care (Enrollment is full, not recruiting)
New Britain, Connecticut, 06053, United States
-
Jefferson Hospital (Enrollment is full, not recruiting)
Philadelphia, Pennsylvania, 19107, United States
-
Massachusetts General Hospital (Enrollment is full, not recruiting)
Boston, Massachusetts, 02114, United States
-
Northwestern (Enrollment is full, not recruiting)
Chicago, Illinois, 60611, United States
-
Nova Southeastern University
Davie, Florida, 33314, United States
-
Penn State Health (Enrollment is full, not recruiting)
Hershey, Pennsylvania, 17033, United States
-
Providence Health (Enrollment is full, not recruiting)
Portland, Oregon, 97225, United States
-
Sutter Health (Enrollment is full, not recruiting)
San Francisco, California, 94107, United States
-
Texas Neurology
Dallas, Texas, 75206, United States
-
UC Irvine
Orange, California, 92868, United States
-
University of Kansas (Enrollment is full, not recruiting)
Fairway, Kansas, 66205, United States
-
University of Nebraska Medical Center (Enrollment is full, not recruiting)
Omaha, Nebraska, 68198, United States
-
University of Washington
Seattle, Washington, 98195, United States
Conditions
Explore the condition pages connected to this study.